Company Overview
- Headquarters
- 44 Milton Ave, Alpharetta GA
- Website
- virios.com
- Phone
- (866) 620-8655
- Employees
- 1
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:VIR
- NAICS Code
-
NAICS Code 62 CompaniesNAICS Code 54 CompaniesNAICS Code 62139 CompaniesNAICS Code 6213 CompaniesNAICS Code 621 CompaniesNAICS Code 621399 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 804 CompaniesSIC Code 873 CompaniesSIC Code 87 CompaniesSIC Code 80 Companies
Financials & Stats
Revenue
$1B
Who is Virios Therapeutics
Virios Therapeutics is a clinical-stage biopharmaceutical company headquartered in Alpharetta, Georgia. With a team of four employees, Virios Therapeutics is focused on developing and commercializing novel antiviral therapies. The company specializes in treatments for diseases stemming from an abnormal immune response triggered by viruses, particularly fibromyalgia (FM). Virios Therapeutics' lead candidate, IMC-1, has been granted fast track designation by the FDA, signifying its potential to address a significant medical need. What sets Virios Therapeutics apart is its executive team's profound experience in successfully developing therapies for FM. This expertise positions them strategically to navigate the complexities of bringing innovative antiviral treatments to market. For more information about Virios Therapeutics and its groundbreaking research, please visit their website at virios.com.
Virios Therapeutics Industry Tags
Virios Therapeutics Tech Stack
Companies Similar to Virios Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Virios Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 9 | Watertown, MA | 2014 | |
| 1M | 4 | South Bend, IN | 1993 | |
| 1M | 10 | Darien, CT | 2006 | |
| 1M | 10 | Palm Beach Gardens, FL | 2015 | |
| 1M | 8 | Kirkland, WA | 2008 |